(PharmaNewsWire.Com, February 26, 2018 ) The Middle East and Africa mycoplasma testing market was worth USD 46.52 Million in 2016 and is estimated to be growing at a CAGR of 8.34%, to reach USD 69.4 Million by 2021. Mycoplasma is a unique type of bacteria among prokaryotes. It is the smallest living microorganism discovered till date and it is not visible even to a light microscope. Mycoplasma contamination is an increasing concern for researchers in life sciences and cell culture.
They are also extremely contagious. Once a cell line is infected, they potentially spread through other culture also. As an estimate, 15-30% of cell cultures are contaminated with mycoplasma in the laboratories. They are capable of altering the metabolic features of a cell and once increased to a certain concentration; they fight with the existing cells in the medium over nutrients. It can alter the chromosomes of cell line also. It is highly recommended to conduct mycoplasma testing for the new arrivals in the laboratory and the cell bank itself to avoid contamination.
Growing concern for increase in mycoplasma infections in cell cultures which render the experiments conducted useless are the major factors driving the mycoplasma testing market. Increase in funding for researches on life sciences and rising number of pharmaceutical and biotechnology industries are also propelling the mycoplasma testing market. Firm government obligations and high consolidation of market are restraining the market growth.
Kits & Reagent PCR Assays Nucleic Acid Detection Kits Elimination Kits & Reagents Stains Standards & Controls Other Kits & Reagents Instruments Services Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product Technique
PCR ELSA Direct Assays Indirect Assays Microbial culture techniques Enzymatic Methods DNA Staining Y-o-Y Growth Analysis, By Technique Market Attractiveness Analysis, By Technique Market Share Analysis, By Technique Application
Cell Line Testing Virus Testing End-Of-Production Cell Testing Other Applications Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application End User
Pharmaceutical Companies Contract Research Organizations Academic Research Institutes Cell Banks Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User Mycoplasma testing market in this region is analyzed under Middle East and Africa regions. Middle East region has witnessed a significant growth in recent years and is expected to continue during the forecast period. Developed countries of Africa region such as South Africa have increased the funding for cell culture research but the growth rate of mycoplasma testing market is somewhat less than the Middle East region.
Some of the major companies in Middle East and Africa region involved in mycoplasma testing market are Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, PromoCell GmbH, Charles River Laboratories International, Inc., InvivoGen, Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
